IP Library Granted Patent US 8,071,141
Granted Patent B2
US 8,071,141 · App. 11/206,073 · Granted Dec 6, 2011

Compositions for preventing or ameliorating multiple risk factor syndromes

Assignee: Kaneka Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,071,141
App. No.
11/206,073
Granted
Dec 6, 2011
Kind
B2
Abstract

A composition for preventing or ameliorating multiple risk factor syndrome involving visceral fat-type obesity, diabetes mellitus, hyperlipemia and hypertension, which comprises at least one member selected from the group consisting of a licorice hydrophobic extract, a turmeric extract, a clove extract, and a cinnamon extract.

Claims (16)

1. A method for ameliorating multiple risk factor syndrome including visceral fat-type obesity, which comprises administrating to a subject suffering from multiple risk factor syndrome and visceral fat-type obesity wherein the multiple risk factor syndrome is a syndrome which co-develops visceral fat-type obesity and at least one member selected from the group consisting of diabetes mellitus, hyperlipemia and hypertension, a composition comprising a licorice hydrophobic extract, wherein the glycyrrhizin content in the licorice hydrophobic extract is not more than 0.4%; and wherein the licorice hydrophobic extract is an extract obtained by extracting out the licorice with ethyl acetate and/or ethanol or an extract from which the ethyl acetate and/or ethanol extractant solvent has been removed.

2. The method according to claim 1 , wherein the composition is orally administered to the subject.

3. The method according to claim 1 , wherein the licorice hydrophobic extract is obtained by extracting out the hydrophilic component of licorice with water or an alkaline aqueous solution in advance and extracting the licorice residue, either as it is or after drying, with said solvent ethyl acetate and/or ethanol.

4. The method according to claim 1 , wherein the composition is a food or beverage.

5. The method according to claim 1 , wherein the composition is a medicinal agent.

6. The method according to claim 1 , wherein the subject is a human being.

7. The method according to claim 1 , wherein the subject is a domestic or pet animal.

8. The method according to claim 1 , wherein the composition is a cosmetic.

9. A method for ameliorating visceral fat-type obesity, which comprises administrating to a subject suffering from visceral fat-type obesity, a composition comprising a licorice hydrophobic extract, wherein the glycyrrhizin content in the licorice hydrophobic extract is not more than 0.4%; and wherein the licorice hydrophobic extract is an extract obtained by extracting out the licorice with ethyl acetate and/or ethanol or an extract from which the ethyl acetate and/or ethanol extractant solvent has been removed.

10. The method according to claim 9 , wherein the composition is orally administered to the subject.

11. The method according to claim 9 , wherein the licorice hydrophobic extract is obtained by extracting out the hydrophilic component of licorice with water or an alkaline aqueous solution in advance and extracting the licorice residue, either as it is or after drying, with said solvent ethyl acetate and/or ethanol.

12. The method according to claim 9 , wherein the composition is a food or beverage.

13. The method according to claim 9 , wherein the composition is a medicinal agent.

14. The method according to claim 9 , wherein the subject is a human being.

15. The method according to claim 9 , wherein the subject is a domestic or pet animal.

16. The method according to claim 9 , wherein the composition is a cosmetic.

Assignments (1)
CHANGE OF ADDRESS Recorded Jan 15, 2014
From: KANEKA CORPORATION
To: KANEKA CORPORATION
Reel/Frame 032019/0901 →
Priority Claims (3)
JP 2000-376930 · Dec 12, 2000 · national
JP 2001-106216 · Apr 4, 2001 · national
JP 2001-191628 · Jun 25, 2001 · national
Continuity (2)
Continuation 10433089
Related Publication 20050287233A1 · Dec 29, 2005